Product Information
PYRIDOSTIGMINE 60 MG/5 ML SOLN is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $0.5648 per ML under NDC 42192062616. Its NADAC has been published 121 times since Jun 12, 2024.
FDA first approved this application on Apr 19, 2022. Its Orange Book therapeutic-equivalence code is AA.
Strength
60 mg/5mL
Manufacturer
Acella Pharmaceuticals, LLCNDC
42192062616
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212405FDA Approved
4/19/2022
TE Code
AA
On Market Since
10/9/2023
Pharmacological Classes
Price Statistics
The NADAC for PYRIDOSTIGMINE 60 MG/5 ML SOLN has been published 121 times since Jun 12, 2024, and over the history we have for it it has declined 37.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5648 per ML |
|---|---|
| All-time high | $1.0061 (Feb 12, 2025) |
| All-time low | $0.4572 (Jul 22, 2026) |
| 52-week high | $0.7605 |
| 52-week low | $0.4572 |
| Median price | $0.8376 |
| Average price | $0.7498 |
| Largest weekly change | +15.8% (Nov 20, 2024) |
| Weeks tracked | 121 |
| Tracking since | Jun 12, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Acella Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pyridostigmine bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PYRIDOSTIGMINE 60 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for PYRIDOSTIGMINE 60 MG/5 ML SOLN, manufactured by Acella Pharmaceuticals, LLC, is $0.5648 per ML (NDC 42192062616), effective Sep 30, 2026.
How has the price of PYRIDOSTIGMINE 60 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for PYRIDOSTIGMINE 60 MG/5 ML SOLN has declined 37.8%. It has been tracked across 121 weekly CMS publications since Jun 12, 2024.
What are the highest and lowest recorded NADAC prices for PYRIDOSTIGMINE 60 MG/5 ML SOLN?
Since Jun 12, 2024, the NADAC for PYRIDOSTIGMINE 60 MG/5 ML SOLN has ranged from a low of $0.4572 (Jul 22, 2026) to a high of $1.0061 (Feb 12, 2025), with a median of $0.8376 per ML.
Are there cheaper alternatives to PYRIDOSTIGMINE 60 MG/5 ML SOLN?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PYRIDOSTIGMINE 60 MG/5 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures PYRIDOSTIGMINE 60 MG/5 ML SOLN?
PYRIDOSTIGMINE 60 MG/5 ML SOLN (NDC 42192062616) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.